Debt-to-equity of Editas Medicine, Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Editas Medicine, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Editas Medicine, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 344%, a 501% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Editas Medicine, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 344% +287% +501% 30 Sep 2025
Q2 2025 192% +144% +300% 30 Jun 2025
Q1 2025 118% +77% +185% 31 Mar 2025
Q4 2024 79% +38% +93% 31 Dec 2024
Q3 2024 57% +16% +40% 30 Sep 2024
Q2 2024 48% +11% +28% 30 Jun 2024
Q1 2024 41% +7% +21% 31 Mar 2024
Q4 2023 41% +13% +45% 31 Dec 2023
Q3 2023 41% +17% +70% 30 Sep 2023
Q2 2023 37% +15% +65% 30 Jun 2023
Q1 2023 34% +12% +53% 31 Mar 2023
Q4 2022 28% +6% +25% 31 Dec 2022
Q3 2022 24% -3% -10% 30 Sep 2022
Q2 2022 23% -7% -24% 30 Jun 2022
Q1 2022 22% -15% -40% 31 Mar 2022
Q4 2021 23% -31% -58% 31 Dec 2021
Q3 2021 27% -37% -58% 30 Sep 2021
Q2 2021 30% -47% -61% 30 Jun 2021
Q1 2021 37% -52% -58% 31 Mar 2021
Q4 2020 53% -30% -36% 31 Dec 2020
Q3 2020 63% -15% -19% 30 Sep 2020
Q2 2020 77% 0% -0.56% 30 Jun 2020
Q1 2020 89% +15% +21% 31 Mar 2020
Q4 2019 83% +12% +17% 31 Dec 2019
Q3 2019 78% +7% +10% 30 Sep 2019
Q2 2019 77% +3% +3.4% 30 Jun 2019
Q1 2019 74% -8% -9.4% 31 Mar 2019
Q4 2018 71% -19% -21% 31 Dec 2018
Q3 2018 71% -18% -20% 30 Sep 2018
Q2 2018 75% -3% -3.6% 30 Jun 2018
Q1 2018 81% +22% +36% 31 Mar 2018
Q4 2017 90% +50% +126% 31 Dec 2017
Q3 2017 89% +44% +98% 30 Sep 2017
Q2 2017 77% 30 Jun 2017
Q1 2017 60% 31 Mar 2017
Q4 2016 40% 31 Dec 2016
Q3 2016 45% 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.